KOSPI · Healthcare · ₩179B
₩7,790+1.96%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 6.8% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기, 매출과 이익이 함께 회복됐어요.”
In the company's words · 2026 2분기 filing